Wegovy Shortage April 2024 Olympics. Danish pharmaceutical giant novo nordisk will boost supplies of its wildly popular obesity drug wegovy in the united states this year, mitigating—but likely not. It’s frustrating for people who are relying on.

Sales of novo nordisk’s obesity drug wegovy slowed over the first three months of 2024, compared to the fourth quarter last year, as lower realized prices and. Ozempic and wegovy use has skyrocketed over the past few years and now there are shortages for many patients.